NU
Nunzia Pharmaceutical Company
NUNZ · OTC
$0.00 +0.00% (+$0.00)
Market Cap $43.5K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
-
N/A EV/EBITDA N/A
P/S N/A
P/B N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
-
N/A ROE N/A
ROA N/A
Asset turnover N/A
Debt
-
N/A Current ratio N/A
Int. coverage N/A
Net debt/EBITDA N/A
Stability
19 /100
Unstable EPS volatility 202,051.15%
Profitable years 0
Beta -2.87x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o NUNZ
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Sara Gonzales
Employees
4
Headquarters
Long Beach